Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Celldex Therapeutics, Inc.
AI Executive Summary
AI-powered analysis of 8-K filing content
Celldex Therapeutics raised $282 million through a public offering of 10.3 million shares at $29 per share on April 1, 2026. This significant capital raise strengthens the company's balance sheet and provides funding for strategic operations and future initiatives.
Key Takeaways
Celldex sold 10,345,000 shares of common stock at $29.00 per share in a public offering
Net proceeds of approximately $282 million after underwriting discounts and expenses
3 more takeaways